Strong Probiotics Demand in Americas Drives Up BioGaia's Q2 Sales
Executive Summary
Higher sales of probiotics in the Americas and APAC helps offset a drop in turnover in EMEA for Sweden-based BioGaia in Q2.
You may also be interested in...
People On The Move: Appointments At BioGaia, Futura, Unilever
A round-up of recent appointments in Europe's health and wellness markets: Swedish probiotics player BioGaia has named its next CEO, while Futura and Unilever have new chairmen.
People On The Move: Appointments At Orkla, PAGB, Afepadi
A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.
Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.